相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides
Kariem Ezzat et al.
FASEB JOURNAL (2012)
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery
Yoshitsugu Aoki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Restoring Dystrophin Expression in Duchenne Muscular Dystrophy Muscle Progress in Exon Skipping and Stop Codon Read Through
Eric P. Hoffman et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Exon-skipping therapy for Duchenne muscular dystrophy
Akinori Nakamura et al.
LANCET (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies
Kinga I. Gawlik et al.
SKELETAL MUSCLE (2011)
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
Hong M. Moulton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
RNA-targeted splice-correction therapy for neuromuscular disease
Matthew J. A. Wood et al.
BRAIN (2010)
Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
Hans Heemskerk et al.
MOLECULAR THERAPY (2010)
In-frame Dystrophin Following Exon 51-Skipping Improves Muscle Pathology and Function in the Exon 52-Deficient mdx Mouse
Yoshitsugu Aoki et al.
MOLECULAR THERAPY (2010)
Functional Rescue of Dystrophin-deficient mdx Mice by a Chimeric Peptide-PMO
HaiFang Yin et al.
MOLECULAR THERAPY (2010)
Antisense PMO Found in Dystrophic Dog Model Was Effective in Cells from Exon 7-Deleted DMD Patient
Takashi Saito et al.
PLOS ONE (2010)
Our trails and trials in the subsarcolemmal cytoskeleton network and muscular dystrophy researches in the dystrophin era
Eijiro Ozawa
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2010)
Toward an Oligonucleotide Therapy for Duchenne Muscular Dystrophy: A Complex Development Challenge
Matthew J. A. Wood
SCIENCE TRANSLATIONAL MEDICINE (2010)
Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
A Renaissance for Antisense Oligonucleotide Drugs in Neurology
Toshifumi Yokota et al.
ARCHIVES OF NEUROLOGY (2009)
Cellular Uptake of Neutral Phosphorodiamidate Morpholino Oligomers
Patrick L. Iversen et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2009)
Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo
H. M. Moulton et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate
Adams Amantana et al.
BIOCONJUGATE CHEMISTRY (2007)
Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers
A Amantana et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
QL Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides
HM Moulton et al.
BIOCONJUGATE CHEMISTRY (2004)
Neutrally charged phosphorodiamidate morpholino antisense oligomers: Uptake, efficacy and pharmacokinetics
V Arora et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2004)
ESEfinder: a web resource to identify exonic splicing enhancers
L Cartegni et al.
NUCLEIC ACIDS RESEARCH (2003)
Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for α2 chain of laminin)
V Allamand et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers
C Ghosh et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2000)
分享论文
